Drug profile · INN
dexlansoprazole
DEXLANSOPRAZOLE
- US status
- approved
- Patents linked
- 6
- News articles
- 0
Quick answer
dexlansoprazole (DEXLANSOPRAZOLE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 9114085
Modified release pharmaceutical compositions of dexlansoprazole
granted -
US 8758818
Oral tablet compositions of dexlansoprazole
granted -
US 8753682
Dual release oral tablet compositions of dexlansoprazole
granted -
US 8741345
Modified release pharmaceutical compositions of dexlansoprazole
granted -
US 8563034
Dual release oral tablet compositions of dexlansoprazole
granted -
US 8563035
Oral tablet compositions of dexlansoprazole
granted
Frequently asked questions
What is dexlansoprazole?
dexlansoprazole (DEXLANSOPRAZOLE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dexlansoprazole?
DEXLANSOPRAZOLE is a marketed brand name for dexlansoprazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dexlansoprazole?
dexlansoprazole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.